Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Current Oncology (Toronto, Ont.)|May 15, 2023
Pancreatic Ductal Adenocarcinoma and Immune Checkpoint Inhibitors: The Gray Curtain of Immunotherapy and Spikes of LightsRita Balsano, Valentina Zanuso, Angelo Pirozzi, et al.
Medicine|March 19, 2019
Incidental finding of non-Hodgkin's lymphoma in a patient affected by castration-sensitive prostate cancer: A case reportAngelo Pirozzi, Giacomo Cartenì, Sarah Scagliarini, et al.
Journal of Hepatocellular Carcinoma|October 9, 2023
Safety and Efficacy of Atezolizumab and Bevacizumab Combination as a First Line Treatment of Advanced Hepatocellular CarcinomaValentina Zanuso, Angelo Pirozzi, Rita Balsano, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 4, 2026
Successful Management of BRAF V600E-Mutated Metastatic Colorectal Cancer With Liver Dysfunction Using Encorafenib-Based TherapyCeline Hoyek, Angelo Pirozzi, Kelley Rone, et al.
Medicine|July 24, 2019
Occurrence of second primary malignancies in patients with neuroendocrine tumors of the digestive tract: A case reportAngelo Pirozzi, Ferdinando Riccardi, Grazia Arpino, et al.
Clinical Advances in Hematology & Oncology : H&O|February 20, 2026
Multikinase inhibitors in refractory metastatic colorectal cancer: an optimal sequence?Celine Hoyek, Angelo Pirozzi, Naohiro Okano, et al.
BMC Infectious Diseases|July 9, 2021
Hepatitis C virus infection and risk of liver-related and non-liver-related deaths: a population-based cohort study in Naples, southern ItalyPierluca Piselli, Diego Serraino, Mario Fusco, et al.
Epidemiologia E Prevenzione|February 10, 2021
[Mortality Atlas of the Campania Region. All-cause and cause-specific mortality at municipal level, 2006-2014]Mario Fusco, Antonella Guida, Ettore Bidoli, et al.
Expert Opinion on Pharmacotherapy|May 4, 2022
Advances in drug treatments for mesotheliomaPaolo Andrea Zucali, Fabio De Vincenzo, Matteo Perrino, et al.
Expert Opinion on Drug Safety|May 1, 2025
Pharmacologic features, clinical applications, and drug safety evaluation of futibatinib in the treatment of biliary tract cancer (BTC)Angelo Pirozzi, Celine Hoyek, Naohiro Okano, et al.
Pageof 3